Cargando…
Cost of illness of urothelial bladder cancer in Italy
BACKGROUND: Urothelial bladder cancer (UBC) is the ninth most common cancer worldwide. In Italy, the prevalence of the disease is approximately 10%, making it the fourth most prevalent cancer in the country. The increase in prevalence requires continuous surveillance and care, resulting in a signifi...
Autores principales: | Gerace, Claudio, Montorsi, Francesco, Tambaro, Rosa, Cartenì, Giacomo, De Luca, Stefano, Tucci, Marcello, Martorana, Giuseppe, Basso, Umberto, Cardosi, Leonardo, Teruzzi, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533568/ https://www.ncbi.nlm.nih.gov/pubmed/28769578 http://dx.doi.org/10.2147/CEOR.S135065 |
Ejemplares similares
-
The interplay of extracellular matrix and microbiome in urothelial bladder cancer
por: Alfano, Massimo, et al.
Publicado: (2015) -
Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study
por: Montella, Maurizio, et al.
Publicado: (2015) -
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)
por: Bersanelli, Melissa, et al.
Publicado: (2021) -
Bladder Cancer and Urothelial Impairment: The Role of TRPV1 as Potential Drug Target
por: Mistretta, Francesco, et al.
Publicado: (2014) -
Cost analysis of extended half-life recombinant factor IX products in the treatment of haemophilia B in Italy: an update
por: Aiello, Andrea, et al.
Publicado: (2022)